Endothelin antagonists for diabetic and non-diabetic chronic kidney disease. - Wikidata - awgldk - TriplyDB

Endothelin antagonists for diabetic and non-diabetic chronic kidney disease.

Endothelin antagonists for diabetic and non-diabetic chronic kidney disease.

http://www.wikidata.org/entity/Q37219055

about

Present and future in the treatment of diabetic kidney disease Inhibition of ENaC by endothelin-1 The role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsis The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis Plasma pro-endothelin-1 peptide concentrations rise in chronic kidney disease and following selective endothelin A receptor antagonism.Endothelin-1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen species Novel drugs and intervention strategies for the treatment of chronic kidney disease.Matrix Producing Cells in Chronic Kidney Disease: Origin, Regulation, and Activation.Predictors of congestive heart failure after treatment with an endothelin receptor antagonist.Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy.First-in-Man Demonstration of Direct Endothelin-Mediated Natriuresis and Diuresis.G Protein-Coupled Receptor-G-Protein βγ-Subunit Signaling Mediates Renal Dysfunction and Fibrosis in Heart Failure.Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1.Endothelin antagonists in diabetic nephropathy: back to basics.Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD).

P2860

Q26864133-7AB5861B-CEE5-45BD-9599-4133EFDFF47B Q27005957-28EAF2F0-0439-426D-9A53-0060D42A8BA9 Q27009064-F819BAF7-4D6A-48A5-99B5-41A4117C6083 Q28237978-2F41786C-0B5E-476B-BE0B-3437AEE8E18D Q28468441-4E8BBEBA-290A-4ADF-851B-102977A3F7C5 Q35354175-16DF98F0-7558-4D80-A9BF-B51B596C1C99 Q37084544-03B380A9-9F24-481D-97EE-C9FBF21D8403 Q37219043-89C54FCF-93C6-4D2D-8A8E-6529AB4B5FEA Q37364008-AA01039A-1C3B-4F1B-BD17-C4385CF7C3E3 Q37621556-A16F0A08-9238-41AE-99EE-E23E73BC9320 Q37733555-9ABD51F8-C67A-436C-A335-09A49C8D1FAF Q38746316-BF34D67C-9AE4-46D7-9D0B-20F88EFCDF35 Q38784727-DCF81345-C2FB-4900-B031-BC8D0B0DE0D6 Q39685882-3D267D38-7362-4946-BD85-BBE099988425 Q40973688-3FAA7978-0BCC-44C9-85BD-60895E804392 Q42547440-192F64E5-F85A-46FA-83CD-75812727CBB1 Q47216784-02A7173E-9297-4610-BDDF-F8062F7031D3 Q55476982-4CF975DF-FA37-4C05-838F-FF3E113917AE

P2860

Endothelin antagonists for diabetic and non-diabetic chronic kidney disease.

http://www.wikidata.org/entity/Q37219055

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Endothelin antagonists for diabetic and non-diabetic chronic kidney disease.

@en

Endothelin antagonists for diabetic and non-diabetic chronic kidney disease.

@nl

type

label

Endothelin antagonists for diabetic and non-diabetic chronic kidney disease.

@en

Endothelin antagonists for diabetic and non-diabetic chronic kidney disease.

@nl

prefLabel

Endothelin antagonists for diabetic and non-diabetic chronic kidney disease.

@en

Endothelin antagonists for diabetic and non-diabetic chronic kidney disease.

@nl

P1433

Q37219055-A9E5BC85-C8A6-4B90-B3E3-4AEB8D960AA4

P1476

Q37219055-4F42DACA-B647-417D-B847-74C37F625D89

P2093

Q37219055-106351A2-54DC-40AF-B12C-D0E82CD0808E

Q37219055-8BE8D5C6-FF09-4D70-8E68-5559735FBF66

P2860

Q37219055-06A36181-3220-466B-8BD4-4C0ECBDF8623

Q37219055-09DACC29-A942-493F-BEB9-45DC0AB4E78F

Q37219055-0C3B8D12-BF30-41DF-96C4-07B026E73F13

Q37219055-0E76A85C-31AD-46B0-910E-222349ED8D59

Q37219055-137E01B5-A3D0-4DEF-8138-F3B788894987

Q37219055-1471C764-715D-4CB7-AF8C-FCBC5F25A9D2

Q37219055-15B98E13-F7FE-48CD-8AF6-BE071E15C531

Q37219055-1C36F88E-542A-4CFD-82CB-D28F07EDBD7B

Q37219055-34625AD0-E7F7-49AC-8457-4DB0B4979655

Q37219055-3C3CD801-FDC0-4157-90A2-F3E49D767FAA

P304

Q37219055-5734E230-0DD4-4E16-9EDF-F8AF581A5A1A

P31

Q37219055-43C2A3E4-6FEA-4455-9131-8A53E487CE1E

Q37219055-55fa8e5a-afd9-4d8d-ad65-a00cee932c1a

P356

Q37219055-41C8A8A6-935D-456C-9DDA-8EA5C814086F

P407

Q37219055-03B99710-7831-48B7-A107-F66AB0312ADF

P433

Q37219055-3E08CD00-6C41-4FDC-99BC-734C6763EDD0

P478

Q37219055-427F3CF5-DBA7-423F-BAD9-E8476493CA9F

P577

Q37219055-E3D235F6-C488-49CB-B186-B21CFDC723CB

P698

Q37219055-CC48202F-4180-49B5-928B-2491A61B943A

P932

Q37219055-3CEDFA2B-AFD3-4FC0-9497-59D4078C306C

P356

P1433

British Journal of Clinical Pharmacology

P1476

Endothelin antagonists for diabetic and non-diabetic chronic kidney disease.

@en

P2093

David M Pollock

http://www.w3.org/2001/XMLSchema#string

Donald E Kohan

http://www.w3.org/2001/XMLSchema#string

P2860

Avosentan reduces albumin excretion in diabetics with macroalbuminuria

Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat

Avosentan for overt diabetic nephropathy.

Endothelin antagonists and renal protection.

Chronic endothelin-1 infusion elevates glomerular sieving coefficient and proximal tubular albumin reuptake in the rat

Clinical trials with endothelin receptor antagonists: what went wrong and where can we improve?

Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension.

Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy.

New therapeutics that antagonize endothelin: promises and frustrations.

Endothelin but Not Angiotensin II May Mediate Hypertension-Induced Coronary Vascular Calcification in Chronic Kidney Disease

P304

573-579

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.12064

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23228194

http://www.w3.org/2001/XMLSchema#string

P932

3791980

http://www.w3.org/2001/XMLSchema#string